Found: 26
Select item for more details and to access through your institution.
Clinical Impact of Primary Tumor Location in Metastatic Colorectal Cancer Patients Under Later-Line Regorafenib or Trifluridine/Tipiracil Treatment.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.688709
- By:
- Publication type:
- Article
Survival Benefit of Crossover Administration of Regorafenib and Trifluridine/Tipiracil Hydrochloride for Patients With Metastatic Colorectal Cancer: Exploratory Analysis of a Japanese Society for Cancer of the Colon and Rectum Multicenter Observational Study (REGOTAS)
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.576036
- By:
- Publication type:
- Article
Acute Liver Failure with Diffuse Liver Metastasis from Breast Cancer, Not Detected by Computed Tomography: 2 Case Reports.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Outcome of Surgical Treatment for Metastatic Vertebra Bone Tumor in Advanced Lung Cancer.
- Published in:
- Case Reports in Oncology, 2010, v. 3, n. 1, p. 63, doi. 10.1159/000299385
- By:
- Publication type:
- Article
Correction to: Multicenter phase II study of trastuzumab plus S-1 alone in elderly patients with HER2-positive advanced gastric cancer (JACCRO GC‑06).
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
Multicenter phase II study of trastuzumab plus S-1 alone in elderly patients with HER2-positive advanced gastric cancer (JACCRO GC-06).
- Published in:
- Gastric Cancer, 2018, v. 21, n. 3, p. 421, doi. 10.1007/s10120-017-0766-x
- By:
- Publication type:
- Article
Clinical Significance of Pretreatment C-Reactive Protein in Patients with Advanced Nonsquamous, Non-Small Cell Lung Cancer Who Received Gefitinib.
- Published in:
- Oncology, 2011, v. 79, n. 5/6, p. 355, doi. 10.1159/000323486
- By:
- Publication type:
- Article
Evaluation of health-related quality of life via the Computer-Based Health Evaluation System (CHES) for Japanese metastatic breast cancer patients: a single-center pilot study.
- Published in:
- Breast Cancer (13406868), 2019, v. 26, n. 2, p. 255, doi. 10.1007/s12282-018-0905-1
- By:
- Publication type:
- Article
Prognostic scores for evaluating the survival benefit of regorafenib or trifluridine/tipiracil in patients with metastatic colorectal cancer: an exploratory analysis of the REGOTAS study.
- Published in:
- International Journal of Clinical Oncology, 2020, v. 25, n. 4, p. 614, doi. 10.1007/s10147-019-01600-0
- By:
- Publication type:
- Article
Phase II study of S-1 on alternate days plus bevacizumab in patients aged ≥ 75 years with metastatic colorectal cancer (J-SAVER).
- Published in:
- International Journal of Clinical Oncology, 2019, v. 24, n. 10, p. 1214, doi. 10.1007/s10147-019-01465-3
- By:
- Publication type:
- Article
Phase I study of primary treatment with 5-FU, oxaliplatin, irinotecan, levofolinate, and panitumumab combination chemotherapy in patients with advanced/recurrent colorectal cancer involving the wild-type <italic>RAS</italic> gene: the JACCRO CC-14 study.
- Published in:
- International Journal of Clinical Oncology, 2018, v. 23, n. 3, p. 490, doi. 10.1007/s10147-017-1228-5
- By:
- Publication type:
- Article
Accuracy of epidermal growth factor receptor gene mutation analysis by direct sequencing method based on small biopsy specimens from patients with non-small cell lung cancer: analysis of results in 19 patients.
- Published in:
- International Journal of Clinical Oncology, 2008, v. 13, n. 5, p. 442, doi. 10.1007/s10147-008-0772-4
- By:
- Publication type:
- Article
A unique case of high‐grade myofibroblastic sarcoma initially presenting with oral symptoms.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Regorafenib vs trifluridine/tipiracil for metastatic colorectal cancer refractory to standard chemotherapies: A multicenter retrospective comparison study in Japan.
- Published in:
- PLoS ONE, 2020, v. 15, n. 6, p. 1, doi. 10.1371/journal.pone.0234314
- By:
- Publication type:
- Article
Association of diffuse, random pulmonary metastases, including miliary metastases, with epidermal growth factor receptor mutations in lung adenocarcinoma.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 4, p. 819, doi. 10.1002/cncr.25618
- By:
- Publication type:
- Article
Prevalence and risk factors of hepatitis B virus reactivation in patients with solid tumors with resolved HBV infection.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2019, v. 15, n. 1, p. 63, doi. 10.1111/ajco.13050
- By:
- Publication type:
- Article
Significance of pretreatment comorbidities in elderly patients with advanced non-small-cell lung cancer treated with chemotherapy or epidermal growth factor receptor-tyrosine kinase inhibitor.
- Published in:
- Medical Oncology, 2012, v. 29, n. 1, p. 185, doi. 10.1007/s12032-010-9764-0
- By:
- Publication type:
- Article
Clinical significance of the ratio between the alpha 2 plasmin inhibitor-plasmin complex and the thrombin-antithrombin complex in advanced non-small cell lung cancer.
- Published in:
- Medical Oncology, 2011, v. 28, n. 1, p. 351, doi. 10.1007/s12032-010-9454-y
- By:
- Publication type:
- Article
Genetic polymorphisms in the endothelial nitric oxide synthase gene correlate with overall survival in advanced non-small-cell lung cancerpatients treated with platinum-based doubletc hemotherapy.
- Published in:
- BMC Medical Genetics, 2010, v. 11, p. 167, doi. 10.1186/1471-2350-11-167
- By:
- Publication type:
- Article
Impact of chronological age on efficacy and safety of fluoropyrimidine plus bevacizumab in older non-frail patients with metastatic colorectal cancer: a combined analysis of individual data from two phase II studies of patients aged >75 years.
- Published in:
- Japanese Journal of Clinical Oncology, 2022, v. 52, n. 7, p. 717, doi. 10.1093/jjco/hyac073
- By:
- Publication type:
- Article
Phase Ib study of irinotecan and ramucirumab for advanced gastric cancer previously treated with fluoropyrimidine with/without platinum and taxane.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Phase I study of the combination of nedaplatin and gemcitabine in previously untreated advanced squamous cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 2, p. 325, doi. 10.1007/s00280-010-1321-1
- By:
- Publication type:
- Article
Clinicopathologic Factors Affecting the Progression-Free Survival of Patients With Advanced Non-Small-Cell Lung Cancer After Gefitinib Therapy.
- Published in:
- Clinical Lung Cancer, 2011, v. 12, n. 1, p. 56, doi. 10.3816/CLC.2011.n.008
- By:
- Publication type:
- Article
First-line chemotherapy with capecitabine/oxaliplatin for advanced gastric cancer: A phase I study.
- Published in:
- Molecular & Clinical Oncology, 2017, v. 7, n. 3, p. 347, doi. 10.3892/mco.2017.1335
- By:
- Publication type:
- Article
Effect of vascular endothelial growth factor polymorphisms on survival in advanced-stage non-small-cell lung cancer.
- Published in:
- Cancer Science, 2009, v. 100, n. 10, p. 1917, doi. 10.1111/j.1349-7006.2009.01253.x
- By:
- Publication type:
- Article
Clinical significance of pretreatment serum amphiregulin and transforming growth factor-α, and an epidermal growth factor receptor somatic mutation in patients with advanced non-squamous, non-small cell lung cancer.
- Published in:
- Cancer Science, 2008, v. 99, n. 11, p. 2295, doi. 10.1111/j.1349-7006.2008.00931.x
- By:
- Publication type:
- Article